Hong Kong Team Makes CAR-T Therapy for Children With Leukaemia in Just 14 Days
A Hong Kong phase II trial of six children found that locally manufactured point-of-care CD19 CAR-T cells, produced in 14 ...
A Hong Kong phase II trial of six children found that locally manufactured point-of-care CD19 CAR-T cells, produced in 14 ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine